Skip to main content
. Author manuscript; available in PMC: 2022 Apr 10.
Published in final edited form as: Cancer Lett. 2021 Jan 17;503:231–239. doi: 10.1016/j.canlet.2021.01.012

Fig. 4. Large hyperplastic lesions in mammary glands from ENU-treated ApcMin/+ and NRL-PRL/ApcMin/+ females exhibit different localization of β-catenin and expression of Notch receptors, which are associated with different levels of target genes regulating proliferation and cell fate.

Fig. 4.

(A) Left, representative large hyperplasias from genotypes shown, stained with H&E. Arrows indicate squamous changes. Right, representative immunohistochemistry for β-catenin, showing markedly different localization between these genotypes. Insets as shown. Scale bars, 100μm. Original magnifications, x200. (B) Relative levels of transcripts in mammary epithelial cell preparations were determined by qRT-PCR. (i) indicators of Wnt and Notch signals. (ii) cell cycle regulators. (iii) Sox genes. Mean ± S.E.M., N=3-4. (*, p<0.05; **, p<0.01, unpaired Student’s t test). (C) Relative levels of transcripts for Notch receptors in mammary epithelial cell preparations were determined by qRT-PCR. Mean ± S.E.M., N=3-4. (*, p<0.05; unpaired Student’s t test). (D) Representative immunohistochemistry for NOTCH1, showing strikingly different levels of expression between these genotypes. Insets as shown. Scale bars, 100μm. Original magnifications, x200.